Rule 2.7, 3.10.3, 3.10.4, 3.10.5
New issue announcement, application for quotation of additional securities and agreementInformation or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity |
RESAPP HEALTH LIMITED |
ABN |
51 094 468 318 |
We (the entity) give ASX the following information.
Part 1 - All issuesYou must complete the relevant sections (attach sheets if there is not enough space).
1 | +Class of +securities issued or to be issued | Employee Incentive Options |
2 | Number of +securities issued or to be issued (if known) or maximum number which may be issued | 750,000 Employee Incentive Options |
3 | Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) | 250,000 Options ($0.45; 31 October 2020) pursuant to the terms of the Company's Employee Incentive Plan. 500,000 Options ($0.45; 12 December 2020) pursuant to the terms of the Company's Employee Incentive Plan. |
4 | Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities? If the additional +securities do not rank equally, please state:
| No. Options will convert into Ordinary Shares. |
5 | Issue price or consideration | Employee Incentive Options issued for nil cash consideration under the Company Employee Incentive Plan. |
6 | Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) | Employee Incentive Options issued to provide an incentive and reward for employees for their contributions to the Company. |
6a | Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i | Yes |
6b | The date the security holder resolution under rule 7.1A was passed | 2 November 2016 |
6c | Number of +securities issued without security holder approval under rule 7.1 | Nil |
+ See chapter 19 for defined terms.
Appendix 3B Page 2 04/03/2013
6d | Number of +securities issued with security holder approval under rule 7.1A | Nil | |
6e | Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) | Nil | |
6f | Number of +securities issued under an exception in rule 7.2 | 750,000 Employee Incentive Options | |
6g | If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation. | Not applicable | |
6h | If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements | Not applicable | |
6i | Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements | Listing Rule 7.1 - 98,855,940 Listing Rule 7.1A - 65,903,960 | |
7 | +Issue dates Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. | 14 February 2017 | |
Number | +Class | ||
8 | Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable) | 596,602,103 | Fully paid ordinary shares |
Number | +Class |
62,437,499 38,437,500 55,312,500 5,000,000 5,000,000 10,000,000 3,000,000 2,000,000 4,500,000 1,866,667 2,000,000 250,000 500,000 2,000,000 2,000,000 7,200,000 7,400,000 | Fully paid ordinary shares (escrowed to 14 July 2017) Performance Shares converting on a 1:1 basis upon the achievement of milestone (escrowed to 14 July 2017) Performance Shares converting on a 1:1 basis upon the achievement of milestone Incentive Options ($0.025; 2 July 2020) Incentive Options ($0.05; 2 July 2020) Incentive Options ($0.10; 2 July 2020) Incentive Options ($0.05; 22 September 2020) Incentive Options ($0.10; 22 September 2020) Unlisted Options ($0.28; 29 April 2019) escrowed for 12 months to 29 April 2017. Unlisted Options ($0.30; 29 April 2019) escrowed for 12 months to 29 April 2017. Employee Incentive Options ($0.45; 16 September 2019) Employee Incentive Options ($0.45; 31 October 2020) Employee Incentive Options ($0.45; 12 December 2020) Consultancy Incentive Options ($0.45; 16 September 2019) Consultancy Incentive Options ($0.75; 16 September 2019) Director Incentive Options ($0.45; 10 November 2019) Director Incentive Options ($0.75; 10 November 2019) |
Number and +class of all
+securities not quoted on ASX (including the +securities in section 2 if applicable)
+ See chapter 19 for defined terms.
Appendix 3B Page 4 04/03/2013
ResApp Health Limited published this content on 14 February 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 19 February 2017 01:23:11 UTC.
Original documenthttp://www.resapphealth.com.au/wp-content/uploads/2017/02/1644377.pdf
Public permalinkhttp://www.publicnow.com/view/D7CDA684E4E2034BDE56AC8D40E19EA726096294